of uPAR in invasion.
When active uPA or the pro-enzyme pro-uPA are bound The GPI-anchored urokinase plasminogen activator to uPAR, they are not internalized and remain on the cell receptor (uPAR) does not internalize free urokinase surface (Vassalli et al., 1985; Stoppelli et al., 1985 , (uPA) but readily internalizes and degrades uPA:serpin 1986; Cubellis et al., 1986) . When receptor-bound uPA is complexes in a process that requires the α 2 -macrocomplexed to the specific plasminogen activator inhibitor globulin receptor/low density lipoprotein receptortype 1 (PAI-1) or to protease nexin-1 (PN-1), the complex related protein (α2MR-LRP). This process is accomis internalized and degraded in the lysosomes (Cubellis panied by the internalization of uPAR which renders et al., 1990; Estreicher et al., 1990; Jensen et al., 1990 ; it resistant to phosphatidylinositol-specific phospholip- Conese et al., 1994) . Binding to uPAR is required for ase C (PI-PLC). In this paper we show that during internalization and degradation of the uPA:PAI-1 and internalization of uPA:serpins at 37°C, analysed by uPA:PN-1 complexes Conese et al., FACScan, immunofluorescence and immunoelectron 1994) and internalization and degradation of the uPA: microscopy, an initial decrease of cell surface uPAR serpin complexes requires a trans-membrane partner which was observed, followed by its reappearance at later has been identified as a member of the LDL-receptor times. This effect was not due to redistribution of family: the α 2 -macroglobulin receptor/low density lipopreviously intracellular receptors, nor to the surface protein receptor-related protein (α2MR-LRP), the epitheexpression of newly synthesized uPAR. Recycling was lial glycoprotein-330 or the VLDL-receptor (Herz et al., directly demonstrated in cell surface-biotinylated, uPA:
1992; Nykjaer et al., 1992; Moestrup et al., 1993 ; Conese PAI-1-exposed cells in which biotinylated uPAR Argraves et al., 1995; Heegaard et al., 1995) . first internalized and subsequently recycled back to
The endocytic α2MR-LRP is expressed by several cultured the surface upon incubation at 37°C. In fact, uPAR cells , and binds a variety of was resistant to PI-PLC after the 4°C binding of ligands, including α2-macroglobulin:proteinase (Moestrup uPA:PAI-1 to biotinylated cells, but upon incubation et al., 1990; Moestrup and Gliemann, 1991) and plasminat 37°C PI-PLC-sensitive biotinylated uPAR reogen activator-serpin complexes (Nykjaer et al., 1992 ; appeared at the cell surface. Binding of uPA:PAI-1 byIntroduction uPA:serpin-internalized uPAR is resistant to release Binding of urokinase plasminogen activator (uPA) to its by PI-PLC specific receptor (uPAR) regulates cell migration and PI-PLC releases cell surface uPAR and hence should release the bound ligand quantitatively. invasiveness (Blasi et al., 1987 Danø et al., 1994;  We incubated LB6 clone 19 cells or activated human ments (not shown). First, we noticed that the intensity of fluorescence in uPA:PAI-1-treated LB6 clone 19 cells primary T-lymphocytes with radiolabelled ligands at 4°C, and compared the releasing effect of acid-washing (which incubated at 37°C for 0-120 min did not decrease over time, as occurred when the uPA antibody was used (not dissociates the ligand) or PI-PLC treatment (which releases the receptor) (Stoppelli et al., 1986; Ploug et al., 1991) on shown; but see Olson et al., 1992) . Figure 1 passing through the adhesion plane. The right series (c, f, i and l, higher magnification) is also a single confocal while PI-PLC released only 36% and 27%, respectively. Treatment with PI-PLC was carried out for 15 min at section (0.2 μm) passing through the centre of the cell. On completion of the 4°C incubation (time 0, not shown), 37°C, while acid-washing was carried out entirely at 4°C. Since internalization causes PI-PLC resistance of uPAR and after 10 min at 37°C (Figure 1 ), staining was concentrated mainly at the cell periphery. After 30 and 60 (Conese et al., 1995) , the results in Table I might be explained by a uPAR-dependent internalization of the min at 37°C, most of the previously peripheral uPAR fluorescence was redistributed to a perinuclear position, ligand occurring within the 37°C PI-PLC incubation time (15 min). Indeed, the α2MR-LRP antagonist RAP shown previously by a variety of techniques to be caused by uPAR internalization (Conese et al., 1995) . The periprevented PI-PLC resistance (Table I ). In agreement with this interpretation, activated T-lymphocytes, which express nuclear location was specific for cells incubated with uPA:serpins and exposed at 37°C, and was inhibited by uPAR but not α2MR-LRP (our unpublished results), displayed identical [ 125 I]uPA:PAI-1 release by PI-PLC and the ligand of α2MR-LRP, RAP (not shown; see Conese et al., 1995) . When the incubation at 37°C was prolonged by the acid treatment (Table I) .
To confirm that a 15-min treatment at 37°C would to 120 min, uPAR fluorescence did not diminish but was found to be re-concentrated at the cell periphery, at sites be sufficient to internalize the uPA:PAI-1 complex, we performed a detailed time-course experiment of uPA:PAI-1 reminiscent of contacts with the plastic dish. This is better seen Figure 1 , panels c, f, i and l (high magnification). In internalization/degradation and confirmed that such conditions were indeed sufficient to attain almost maximal conclusion, these data showed the striking absence of any time-dependent decrease of uPAR staining over the time internalization of the bound uPA:PAI-1, and that this event was suppressed by 200 nM RAP (data not shown).
frame examined, suggesting that internalization of uPAR may not be followed by its degradation. It is important to We conclude therefore that the α2MR-LRP-dependent internalization of uPAR occurs very rapidly at 37°C. We point out that after a 1-h incubation at 37°C, these same cells had already degraded~50% of uPA:PAI-1 also conclude that PI-PLC treatment would not affect internalized uPAR.
(not shown).
Since internalized uPAR is PI-PLC-resistant, treatment of cells with PI-PLC should not eliminate the immunoInternalization of uPAR is not followed by degradation fluorescence signal due to internalized uPAR. We used LB6 clone 19 cells incubated for 90 min at 4°C in the LB6 clone 19 cells previously challenged at 4°C with excess uPA:PAI-1, were incubated at 37°C for different absence of ligands, or in the presence of 10 nM uPA or uPA:PAI-1. In both the absence and presence of ligands, times, treated with anti-uPAR antibodies, and subjected to immunofluorescence confocal microscopy. The staining antibodies to uPAR stained the surface of non-permeabilized cells homogeneously (not shown), as previously was highly specific, as seen in a series of control experi- Fig. 1 . Confocal immunofluorescence microscopy analysis of uPAR in LB6 clone 19 cells challenged with uPA:PAI-1 and then incubated for 10-120 min at 37°C. Cells were incubated with uPA:PAI-1 for 2 h at 4°C, washed and then incubated at 37°C for 10 min (a-c), 30 min (d-f), 60 min (g-i) or 120 min (j-l). Cells were then washed, permeabilized, treated with 15 μg/ml anti-uPAR R2 monoclonal antibody and developed with fluoresceinated anti-mouse IgG. Bars: 35 μm in the panels a, d, g and j; 12 μm in panels c, f, i and l.
reported by Conese et al. (1995) . After 90 min at 4°C, 1992; Conese et al., 1995) . To test for uPAR recycling, the cells were washed, treated with PI-PLC for 15 min at U937 cells were exposed to either uPA:PAI-1 or uPA:PN-1 37°C, and permeabilized. In this case, the signal observed for 90 min at 4°C, washed, further incubated at 37°C, and varied depending on the ligand. In the absence of ligands then subjected to cytofluorimetric analysis with uPARor in the presence of uPA, staining disappeared almost specific antibodies. As expected, uPA:PAI-1 and completely ( Figure 2 , upper and centre panels). When the uPA:rPN-1 complexes down-regulate uPAR after 30 min ligand was uPA:PAI-1, however, uPAR staining disapat 37°C (Figure 3 , panels A, F and B, G) and this was peared from the cell surface and was replaced by an prevented by the α2MR-LRP antagonist, RAP (Figure 3 , intracellular punctuate pattern reminiscent of that seen panels C and H). When, however, the incubation was with internalized proteins (Figure 2, lower panel) . A similar continued for 60 or 120 min, the level of uPAR-specific picture was obtained when the ligand was uPA:rPN-1 (not fluorescence reverted to normal and at 120 min the shown). We conclude that PI-PLC can be employed to FACScan signal was almost identical to that at time zero study the steps following uPAR internalization, as the ( Figure 3 , panels D, E and I, J). This result suggests enzyme will release the surface-bound, but not the internalthat internalized uPAR might be recycled back to the ized, uPAR.
cell surface. The events following internalization of uPAR were also Internalized uPAR recycles back to the cell surface analysed by electron microscopy of cryosections prepared U937 monocyte-like cells incubated with uPA:serpin complexes down-regulate their surface uPAR (Olson et al., for immunocytochemistry, using LB6 clone 19 cells incub- showed that uPAR could at least in part be recycled back washed, permeabilized and subjected to epifluorescence after treatment to the plasma membrane.
with the anti-uPAR monoclonal antibody R2 (see Materials and To directly test recycling of uPAR to the cell surface, methods).
we labelled cell surface uPAR with biotin and then followed its fate after internalization by immunoprecipitation and avidin detection. Surface-biotinylated LB6 clone 19 cells were challenged with uPAR-saturating levels ated and prepared as described in Materials and methods. After incubation for 2 h at 0°C, with 100 nM uPA:PAI-1, (50 nM) of ATF or uPA:PAI-1 for 120 min at 4°C, washed, incubated at 37°C for 15 min and treated with PI-PLC for chase for 15 min at 37°C, and treatment with PI-PLC (protocol a, see Materials and methods), most of the 15 min at 37°C. The PI-PLC supernatant and the cell lysate were immunoprecipitated with uPAR antibodies and labelling (78%) was found over intracellular vacuoles, and 22% on the plasma membrane ( Figure 4A ). However, biotinylated uPAR was detected by avidin-blotting. As shown in Figure 5A , all uPAR was detected in the PI-PLC after chase-incubation at 37°C for 120 min (protocol b), labelling on the plasma membrane rose to 44% and supernatant when the cells were not exposed to any ligand. Figure 5B shows the results of PI-PLC treatment in ligandintracellular vacuolar labelling fell to 56% ( Figure 4B ). To exclude transport of newly synthesized uPAR to treated cells: when cells were exposed to ATF, uPAR was again found in the PI-PLC supernatant; in contrast, when the plasma membrane, all buffers contained 10 μg/ml cycloheximide. Thus, immunoelectron microscopy also cells were incubated with uPA:PAI-1, uPAR was found mostly in the cell lysate, with only a very small fraction The uPA:PAI-1 ligand, though required to initiate the process, is not required for the released into the supernatant. To study recycling, the PI-PLC-treated cells were further incubated at 37°C for internalization/recycling step The binding of the uPA:serpin complex is required to different time intervals and subjected to a second PI-PLC treatment (now 4°C for 90 min) to prevent re-internalizinduce PI-PLC resistance (i.e. internalization) of uPAR (Conese et al., 1995) . Since ligand dissociation by acidation (these conditions were found efficiently to release surface uPAR; not shown). As shown in Figure 5C , in washing does not release uPAR (Stoppelli et al., 1986) , we can test whether the continuous presence of the the case of ATF-challenged cells, PI-PLC supernatants contained little, if any, uPAR. Alternatively, the PI-PLC ligand is required for uPAR internalization and recycling. Unlabelled uPA or uPA:PAI-1 complex (50 nM) was supernatants of uPA:PAI-1-challenged cells showed minor, though significant, uPAR after only 2 min of incubation bound to LB6 clone 19 cells for 120 min at 4°C. The surface-bound ligand was then removed with acid and the at 37°C, and higher levels after 20-30 min of incubation. Concomitantly, uPAR levels were strongly reduced in the washed cells treated with PI-PLC for 15 min at 37°C. The released uPAR was assayed in the PI-PLC supernatant by cell pellet. The detection of biotinylated uPAR on the cell surface clearly indicates that it can recycle back to [ 125 I]ATF cross-linking, SDS-PAGE and autoradiography. The cell pellet was collected, lysed and analysed similarly. that location. Figure 7D ). This result again shows that both internaliz-( Figure 6A ). In uPA:PAI-1-treated cells, the specific [ 125 I]-ation and recycling of uPAR can occur also in suspension ATF-uPAR conjugate was found in the cell-associated growing cells, after dissociation of the ligand. The experifraction, but not in the PI-PLC supernatant ( Figure 6B ). ment also shows that not only uPA:PAI-1, but also The effect was specific, since in uPA-treated cells, uPAR uPA:PN-1 complex caused uPAR internalization and was found in the PI-PLC supernatant. Thus, although recycling. uPA:PAI-1 was required to induce PI-PLC resistance Reversion to PI-PLC sensitivity might also be explained of uPAR at 4°C, its removal did not prevent uPAR by cell surface redistribution of either an intracellular pool internalization.
or of newly synthesized receptors. The latter possibility If the removal of the ligand does not prevent uPAR seems unlikely because identical results were obtained in internalization, it might also not prevent its recycling. Roldan et al., 1990) . We nevertheless tested cross-linking, SDS-PAGE and autoradiography. Control, the effect of the protein synthesis inhibitor cycloheximide, uPA-challenged, LB6 clone 19 cells displayed supernatant in the temperature-dependent reversion to PI-PLC sensiuPAR independently of the time of incubation at 37°C tivity of LB6 clone 19 cells. The data showed that ( Figure 7A ). On the other hand, uPA:PN-1-treated cells treatment of cells with cycloheximide (10 μg/ml, blocking showed no uPAR in the PI-PLC supernatant before the protein synthesis by 90% as shown by 35 S metabolic 37°C incubation (time zero); upon incubation at 37°C, labelling of cells and TCA precipitation of lysates) added uPAR reappeared, increasing linearly with time and reach-30 min before incubation with uPA:PAI-1, had no influence ing a maximum at 60 min ( Figure 7B ). The finding that PI-PLC resistance of uPAR in uPA:PN-1-incubated cells on the result ( Figure 6B ). Thus, recovery of PI-PLC sensitivity did not depend on cell surface exposure of LRP and VLDL-R Nykjaer et al., 1992 Nykjaer et al., , 1994a Heegaard et al., 1995) . In the process, uPAR newly synthesized molecules.
That reversion to PI-PLC sensitivity could not be due itself is internalized through an α2MR-LRP-requiring mechanism (Conese et al., 1995) . When we analysed the to surface re-distribution of a previously intracellular uPAR, was also shown by the absence of such a pool. internalization and degradation of uPA:PAI-1 through uPAR immunofluorescence, we were surprised to find that Data in Figure 6A and B show that the lysates of LB6 clone 19 cells either not exposed to ligand or treated with the signal of internalized uPAR neither decreased nor diminished with time (Figure 1 ), as would occur for the free uPA did not contain any detectable uPAR after treatment with PI-PLC, in agreement with the immunosignal of the ligand . In fact, uPAR was not degraded but was recycled back to the cell surface, fluorescence results of Figure 2 . Indeed, uPAR was found in the lysate before and in the supernatant after PI-PLC as shown by the following experiments. Immunocytofluorimetry with uPA:serpin-incubated U937 cells showed treatment. Finally, we have previously also shown efficient cross-linking to [ 125 I]ATF with intracellular uPAR (Møller that, at 37°C, the uPAR signal after an initial decrease (due to the internalization) could be recovered at later et al., 1992, 1993) ; therefore the failure to detect an intracellular uPAR could not depend on a limitation of times ( Figure 3) . Similar results were obtained by immunoelectron microscopy in EDTA-detached LB6 clone 19 the assay. cells (Figure 4) . Finally, we surface-labelled uPAR with biotin in LB6 clone 19 cells, incubated the cells at 37°C
Discussion
with uPA:PAI-1 to force uPAR internalization, and treated cells with PI-PLC to eliminate non-internalized uPAR. Recycling The ability to internalize and degrade uPA:serpin comUpon further incubation at 37°C, biotinylated uPAR reappeared at the cell surface ( Figure 5 ). Finally, the plexes is a unique property of uPAR in view of the absence of a trans-membrane and cytosolic domain. This can only uPA:PAI-1 and uPA:PN-1-induced resistance of uPAR to release by PI-PLC was reversed in time-dependent manner occur because the uPAR-bound uPA:PAI-1 can interact with proteins of the LDL-receptor family such as α2MR-on incubation at 37°C (Figures 6 and 7 ). All these data show that uPAR can recycle. The uPA:PAI-1 ligand, and an unidentified adaptor molecule (Wei et al., 1994 (Wei et al., , 1996 Bohuslav et al., 1995; Resnati et al., 1996) . however, does not recycle (our unpublished data).
Recycling. While we have shown here the recycling of
Steps involved in uPA:PAI-1 clearance uPAR, we have no information on the mechanism involved. From these and previous results, we can distinguish four Also, while α2MR-LRP is known to be a recycling steps in the internalization of uPA:PAI-1: (i) binding of receptor (Krieger and Herz, 1994) , no information is uPA:PAI-1; (ii) induction of PI-PLC resistance of uPAR; available on whether it recycles in the case of the (iii) endocytosis; and (iv) recycling. While binding of uPA:PAI-1 internalization/degradation process. If so, the uPA:PAI-1 is essential to initiate the process, the other recycling routes of the two receptors still need to be two steps do not require its continuous presence.
defined. Several unsolved problems persist therefore in Binding of uPA:PAI-1 to cell surface. In cells that contain uPA:PAI-1 internalization. For example, the mechanism both uPAR and α2MR-LRP, uPA:PAI-1 at low physioof dissociation of uPA:PAI-1 from uPAR and α2MR-LRP, logical concentrations will preferentially bind to uPAR the endocytotic and recycling routes (preliminary data because of its higher affinity (Cubellis et al., 1990; suggest that uPAR and α2MR-LRP can be observed within et al., 1994a) . Indeed, ATF and not RAP, competes for the same endocytic vesicles; E.I.Christensen, unpublished binding of uPA:PAI-1 (Nykjaer et al., 1992; Olson et al., observations), the molecular basis for the sorting of 1992; Conese et al., 1994) .
uPA:PAI-1 to lysosomes versus uPAR and α2MR-LRP to PI-PLC resistance of uPAR. Indirect data point to the recycling, are issues that need to be addressed in the future. formation of a quaternary complex between uPA:PAI-1, uPAR and α2MR-LRP. Not only uPAR, but also α2MR-Functional relevance LRP antagonists prevent both degradation of uPA:PAI-1/ The ability of uPAR to recycle provides the plasminogen uPA:PN-1 (Nykjaer et al., 1992; Conese et al., 1994) and activation system with a novel property which is highly uPAR internalization. Since the two moieties of uPA:PAI-1 relevant to its central function in the regulation of cell can contact both uPAR and α2MR-LRP, respectively, a migration. The aggressive, invasive phenotype of cancer quaternary complex might be formed in which the uPA: cells is strongly tied to uPAR expression (Hearing et al., PAI-1 complex bridges uPAR and α2MR-LRP. This step 1988; Ossowski, 1988; Crowley et al., 1993 ; Grøndahl-might occur also at 4°C. However, no direct demonstration Hansen et al., 1995; Min et al., 1996) and the uPA/uPAR of the formation of the quaternary complex has so far system appears to be essential in cell recruitment in been made. Interestingly, uPAR becomes PI-PLC-resistant inflammatory response (Bianchi et al., 1996; Gyetko et al., already in the 4°C step, as shown by experiments such as 1996; Resnati et al., 1996) . Several of the individual those described in Figures 6 and 7 (not shown) in which functions of uPAR have been shown to be involved in the whole experiment was carried out at 4°C, including the invasive behaviour of cancer: pro-uPA activation, PI-PLC release (90 min). The mechanism of PI-PLC chemotaxis, cell adhesion, cell recruitment, etc. Moreover, resistance is not clear, but uPAR may either undergo a PAI-1 itself inhibits cell adhesion and migration, through conformational change or be shielded from PI-PLC by, its ability to bind vitronectin and prevention of its interfor example, α2MR-LRP.
action with integrins (Deng et al., 1996; Stefansson and Lawrence, 1996 ; L.Kjøller, L.Ossowski and P.Andreasen, Internalization of the components of the quaternary complex. When the temperature is raised to 37°C, the personal communication). On the other hand, vitronectin itself is a ligand for uPAR and this provides an additional interaction of uPAR-bound uPA:PAI-1 with α2MR-LRP triggers the internalization of the ligand and its degradaadhesion mechanism for cells (Wei et al., 1994) . Thus, uPA/uPAR influence cell migration via both proteolytic, tion, as well as the internalization and recycling of uPAR. However, at this point the presence of the ligand is no i.e. plasminogen activation (Cubellis et al., 1986; Stoppelli et al., 1986; Ellis et al., 1989; Stephens et al., 1989) , longer required for uPAR internalization (Figures 6 and  7) . Thus, an initial step in which binding of the uPA:serpin and non-proteolytic mechanisms, i.e. by direct signalling (adhesion and chemotaxis) (Busso et al., 1994 ; Resnati complex is essential to trigger the subsequent interaction with α2MR-LRP is followed by the ligand-independent et al. Wei et al., 1996) . PAI-1, on the other hand, inhibits both proteolytic activity of uPA and the integrininduction of PI-PLC resistance of uPAR and then by the actual internalization. mediated cell adhesion and migration (Deng et al., 1996; Stefansson and Lawrence, 1996 ; L.Kjøller, L.Ossowski How is uPAR internalized in a α2MR-LRP-dependent way if the ligand is no longer necessary at the time of the and P.Andreasen, personal communication). Thus, the plasminogen activating system is strongly involved in internalization? This might either occur through direct contact between uPAR and α2MR-LRP, independently of the attachment/detachment machinery of cells, a process obviously essential for cell migration. Indeed, uPA -/-the uPA:PAI-1 bridge, or through the intervention of other, hitherto unknown and uncharacterized molecules. A direct homologous recombinant mice are deeply impaired in inflammatory cell recruitment (Gyetko et al., 1996) , and interaction between uPAR and α2MR-LRP has no experimental basis, but would not be surprising given the large the uPAR-binding domain of uPA blocks VEGF and bFGF-induced angiogenesis (Min et al., 1996) . In this size of α2MR-LRP and the heterogeneity of its many ligands (Krieger and Herz, 1994) . The interaction of uPAR context, the ability of uPAR to induce internalization and degradation of PAI-1 and to recycle back to the cell with another protein is also plausible, since uPAR itself has been reported to interact not only with uPA, but also surface appears to be a very important function in the regulation of the attachment/detachment machinery. The with other molecules like vitronectin, integrins, caveolin 1 mg/ml BSA) and treated with 5 U/ml PI-PLC at 37°C for 15 min or uPA/uPAR/PAI-1 system therefore appears to be able to at 4°C for 90 min. On completion of incubation, the supernatants were inform cells on when, how and where to move. It provides recovered by centrifugation and assayed for solubilized uPAR by crossa 'clear' signal through plasminogen activation and uPAR linking to [ 125 I]ATF and SDS-PAGE analysis (see below). In the case occupancy, a 'stop' signal via PAI-1, and a 'walk' signal of LB6 clone 19 cells, 0.2ϫ10 6 cells were used, but methods and conditions were otherwise identical. In some experiments, after PI-PLC through uPA:PAI-1 lysosomal degradation and the contreatment and collection of the supernatants, the pellets were lysed in comitant surface reappearance of naked uPAR. lysis buffer (0.1 M Tris-HCl, pH 8.1, 10 mM EDTA, 1% Triton X-114 and 1% aprotinin) and cross-linked to [ 125 I]ATF as described below.
Materials and methods

Cross-linking to [ 125 I]ATF
Cell lysates or supernatants were cleared at 15 000 g for 10 min at 4°C Materials and tested for uPAR by cross-linking to [ 125 I]ATF (50 000 c.p.m., 1500 Two-chain uPA was obtained from Lepetit SpA (Milan, Italy), courtesy c.p.m./fmol), using 1 mM DSS (disuccinimidyl suberate), as previously of Dr M.L.Nolli. ATF, the amino-terminal fragment of uPA (residues 1-described (Picone et al., 1989) . The samples were analysed by SDS-143) containing the receptor binding site (Stoppelli et al., 1985) was PAGE (12% acrylamide) under non-reducing conditions (Laemmli, obtained from Abbott Laboratories (Chicago, IL), courtesy of Dr Jack 1970). The specificity of the ATF:uPAR conjugate was shown in all Henkin. Recombinant pro-uPA was obtained from Dr Paolo Sarmientos cases by competition with 100 nM unlabelled two-chain uPA or pro-uPA. (Farmitalia, Italy). Anti-uPAR monoclonal antibodies R2, R3 and R4 (Rønne et al., 1991) were purified on a Protein G-Sepharose column
Immunodetection of surface-biotinylated uPAR using a commercial kit (mAbTrap™ G, Pharmacia LKB, Sweden) from Biotinylation of cell surface proteins was carried out on 70-80% hybridoma cell culture supernatant received from Drs E.Rønne and confluent LB6 clone 19 cells. After three washes with phosphate-buffered G.Høyer-Hansen (Copenhagen, Denmark). Recombinant active PAI-1 saline (PBS), cells were incubated with 0.5 mg/ml sulfo-NHS-biotin for (Sherman et al., 1992) was a kind gift from Drs David Ginsburg (Ann 30 min at room temperature. The labelling solution was removed and Arbor, MI) and Tor Ny (Umeå, Sweden); recombinant PN-1 (rPN-1) the procedure repeated once. The cells were then washed three times was a generous gift of Dr Randy Scott (Incyte Co., CA). Preparation of with PBS, treated with ligands and PI-PLC as described in the Results the 39 kDa α2MR-LRP ligand RAP has been described previously section and lysed. The lysate and the PI-PLC supernatant were supple- (Nykjaer et al., 1992) . GST and GST-RAP were kindly provided by Dr mented with antibodies (monoclonals R2, R3 and R4 1 μg/ml each), J.Herz (Herz et al., 1991) . Phosphatidylinositol-specific phospholipase incubated for 1 h at 4°C with gentle rocking. Protein G-Sepharose C (PI-PLC) from Bacillus cereus was from Boehringer Mannheim (50 μl of a 10% suspension) was added, the mixture further incubated (Germany). Benzamidine Sepharose 6B was from Pharmacia (Uppsala, 1 h at 4°C and centrifuged. The precipitate was washed, supplemented Sweden); dimethyl-diphenylpolysiloxane and cycloheximide were from with SDS-sample buffer, heated, centrifuged and the supernatant subSigma Chemical Co. (St Louis, MO). The cross-linker disuccinimidyljected to SDS-PAGE in 12.5% acrylamide. After transfer onto nitrocellusuberate and sulfo-NHS-biotin were obtained from Pierce Chem Co.
lose filter (Schleicher & Schuell, Dassel, Germany) , the blot was blocked (Rockford, IL).
in PBS-3% BSA for 1 h at room temperature. The membrane was then washed six times with TBS-0.5% Tween 20 (TTBS) and incubated in Cell-lines and cell cultures PBS containing 0.5 mM CaCl 2 , 0.5 mM MgCl 2 , 1 M glucose, 10% Growth conditions for the human monocyte-like U937 and for the (v/v) glycerol, 0.3% BSA and [ 125 I]streptavidin (0.6 μCi/ml; Amersham) murine LB6 clone 19 cells, a mouse cell line expressing the human for 30 min at room temperature. After six washes in TTBS, the membrane uPA-receptor, have been previously described (Picone et al., 1989;  was exposed to X-ray film at -80°C. Roldan et al., 1990) .
Mononuclear cells were obtained from the buffy coats of healthy Light microscopic procedures donors by Ficoll gradient sedimentation (Pharmacia, Uppsala, Sweden).
LB6 Clone 19 cells were studied either by conventional epifluorescence Monocytes were separated by adhesion on plastic dishes (60 min at or confocal microscopy: in both cases, the specimens were processed as 37°C, repeated once). T-lymphocytes were then isolated by panning on described (Conese et al., 1995) . Briefly, 0.2ϫ10 6 cells were plated onto anti-CD16 antibodies to remove natural killer cells and passage through 24-well Costar plates containing 1.4 cm 2 round glass coverslips. Cells nylon wool fibres to remove B-lymphocytes. T-lymphocytes were stimuwere fixed in 3% formaldehyde (from paraformaldehyde) in PBS lated with 50 μg/ml PMA and 10 U/ml IL-2 for 48-72 h to induce the pH 7.6-2% sucrose, for 10 min at 4°C to avoid permeabilization. For synthesis of uPAR as previously described (Nykjaer et al., 1994b) . permeabilization, coverslips were soaked, after fixation, for 3-5 min in HEPES-Triton X-100 buffer (20 mM HEPES, pH 7.4, 3 mM MgCl 2 Iodinations and 0.5% Triton X-100). Primary monoclonal anti-uPAR antibody R2 Iodination of ATF or uPA with Iodogen (Pierce Chemical Co.) has been was used at 15 μg/ml in TBS-0.2% bovine serum albumin; a fluoresceindescribed (Behrendt et al., 1990) . Specific activities of the proteins tagged secondary antibody (Protos Immunoresearch, San Francisco, CA) ranged between 2.5ϫ10 5 and 4.0ϫ10 6 c.p.m./pmol. Iodinated uPA was used at a 1:200 dilution in TBS-0.2% bovine serum albumin. retaining enzymatic activity was purified by affinity chromatography on Conventional epifluorescence was carried out on a Zeiss Axiophot benzamidine-Sepharose 6B (Holmberg et al., 1976) . microscope and photomicrographs were recorded on a Kodak T-MAX 400 film exposed at 1000 ISO (Eastman Kodak, Rochester, NY). For Formation of uPA:serpin complexes confocal microscopy, a Sarastro 2000 confocal laser scanning system Labelled uPA:PAI-1 complexes were formed combining benzamidine-(Molecular Dynamics, Sunnyvale, CA) attached to a Zeiss Axioskop Sepharose-purified 125 I-labelled or unlabelled uPA and a 20-fold molar fluorescence microscope was employed. The objectives used were a excess of PAI-1 at room temperature for 1 h. The inhibitor:uPA ratio plan-apochromatic 63ϫ1.4 and a plan-apochromatic 100ϫ1.3 (Carl was experimentally determined to convert Ͼ90% of the uPA to the Zeiss). Optical sections of 0.29 μm thickness were saved as 512ϫ512 complex form as determined by SDS-PAGE analysis (not shown).
pixel images and then processed on a McIntosh computer. Final images Similarly, uPA:rPN-1 was formed at a 1:50 ratio as previously described were printed on photographic quality paper with a Kodak DL-7700 (Conese et al., 1994) . Purified, preformed uPA:PAI-1 complex for sublimation ink printer. immunoelectron microscopy experiments was a kind gift of Dr Peter A.Andreasen and was prepared as described before (Nykjaer et al., 1994a) .
Cytofluorimetric analysis Acid-washed-U937 cells (1ϫ10 6 ) were incubated with uPA:PAI-1 or Release of surface-bound ligand uPA:PN-1 complexes for 2 h at 4°C and then transferred at 37°C for Surface-bound ligands were detached from the plasma membrane either different times. Cells were then washed twice with PBS, and incubated by dissociation with acid-washing (Stoppelli et al., 1986) or by incubating in 0.1 ml PBS and 25 μg/ml of anti-uPAR monoclonal antibody R2. cells with 5 U/ml PI-PLC at 37°C for 15 min.
After 30 min of incubation at 4°C, cells were washed twice with PBS and resuspended in PBS containing a 1:50 dilution of fluoresceinconjugated antibody against mouse IgG (Dakopatts, Copenhagen, PI-PLC sensitivity of uPAR Approximately 2ϫ10 6 U937 cells (previously incubated under conditions Denmark). After 30 min at 4°C, cells were washed twice and analysed by flow cytofluorimetry with a FACScan apparatus (Becton-Dickinson, indicated in the individual experiments) were resuspended in 0.1 ml binding buffer (RPMI-1640 containing 50 mM HEPES, pH 7.4 and San Jose, CA). To express the data, the cell number was plotted against the log of the mean fluorescence intensity, with~5000 cells being Bartke,I., Knapp,W. and Stockinger,H. (1995) Ossowski,L. (1994) Electron microscopy Induction of cell migration by pro-urokinase binding to its receptor: LB6 clone 19 cells (5ϫ10 6 ) were pretreated for 30 min with 10 μg/ml possible mechanism for signal transduction in human epithelial cells. cycloheximide and incubated (protocol a) for 2 h with 100 nM uPA:PAI-J. Cell Biol., 126, 259-270. 1 at 0°C, washed, treated with 5 U/ml PI-PLC at 37°C for 15 min and Conese,M., Olson,D. and Blasi,F. (1994) Protease nexin-1-urokinase then fixed. To demonstrate possible recycling (protocol b), cells were complexes are internalized and degraded through a mechanism that washed after the incubation step with PI-PLC, further incubated for requires both urokinase receptor and α2-macroglobulin receptor. 120 min in the presence of cycloheximide at 37°C, and then fixed J. Biol. Chem., 269, 17886-17892. following detachment from coverslips with EDTA. The cells were fixed Conese,M., Nykjaer,A., Petersen,C.M., Cremona,O., Pardi,R., with 0.1% glutaraldehyde and 2% formaldehyde in 0.1 M sodium Andreasen,P.A., Gliemann,J., Christensen,E.I. and Blasi,F. (1995) , Cassani,G. and Blasi,F. (1986) Binding of Ni grids. The sections were incubated overnight at 4°C with polyclonal single-chain pro-urokinase to the urokinase receptors on human U937 affinity-purified rabbit anti-uPAR IgG (5 μg/ml) and subsequently with cells. J. Biol. Chem., 261, 15819-15822. 10 nm goat anti-rabbit-gold (BioCell, Cardiff, UK) at 4°C for 2 h. The Cubellis,M.V., Wun,T.-C. and Receptor-mediated sections were finally contrasted with methyl cellulose containing 0.3% internalization and degradation of urokinase is caused by its specific uranyl acetate (Tokuyasu, 1978; Griffiths et al., 1984) and studied in a inhibitor PAI-1. EMBO J., 9, 1079-1085. Philips EM208 or Philips CM100 electron microscope.
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Biol., 134, 1563-1571. 
